| NCT03418909 |
Functional Outcome After Treatment for Oropharyngeal Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03418909 |
Active, not recruiting |
Rigshospitalet, Denmark |
2020-03-31 |
| NCT03357107 |
Local Control After Robot-assisted Supraglottic Laryngectomy |
https://ClinicalTrials.gov/show/NCT03357107 |
Completed |
Hospices Civils de Lyon |
2017-02-28 |
| NCT03325738 |
Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective Study |
https://ClinicalTrials.gov/show/NCT03325738 |
Completed |
Centre Antoine Lacassagne |
2017-06-30 |
| NCT03304132 |
The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer |
https://ClinicalTrials.gov/show/NCT03304132 |
Completed |
NYU Langone Health |
2010-12-01 |
| NCT03225157 |
Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation |
https://ClinicalTrials.gov/show/NCT03225157 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-02-28 |
| NCT03162042 |
Role of Myostatin, Activin A and Follistatin Cachexia of ENT Cancers |
https://ClinicalTrials.gov/show/NCT03162042 |
Completed |
University Hospital, Clermont-Ferrand |
2016-02-29 |
| NCT03161613 |
Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in Mexico |
https://ClinicalTrials.gov/show/NCT03161613 |
Recruiting |
Bristol-Myers Squibb |
2019-04-01 |
| NCT03160209 |
HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi |
https://ClinicalTrials.gov/show/NCT03160209 |
Recruiting |
UNC Lineberger Comprehensive Cancer Center |
2020-07-31 |
| NCT03114163 |
Observational Study of Nivolumab in Patients in Germany With Squamous Cell Carcinoma of the Head and Neck Progressing on or After Platinum-Based Therapy |
https://ClinicalTrials.gov/show/NCT03114163 |
Recruiting |
Bristol-Myers Squibb |
2024-07-01 |
| NCT03109457 |
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03109457 |
Completed |
Cairo University |
2018-02-07 |
| NCT03053661 |
Immune Response Evaluation to Curative Conventional Therapy |
https://ClinicalTrials.gov/show/NCT03053661 |
Active, not recruiting |
University of Ulm |
2020-08-31 |
| NCT02879968 |
Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT02879968 |
Completed |
Prince of Songkla University |
2018-08-31 |
| NCT02852343 |
One-step Nucleic Acid Amplification for Detecting Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02852343 |
Completed |
Rennes University Hospital |
2016-12-21 |
| NCT02778191 |
Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02778191 |
Completed |
University Medical Center Groningen |
2017-03-31 |
| NCT02672254 |
New Strategies Against Cutaneous Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02672254 |
Completed |
Corporacion Parc Tauli |
2016-01-31 |
| NCT02663583 |
Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell |
https://ClinicalTrials.gov/show/NCT02663583 |
Recruiting |
M.D. Anderson Cancer Center |
2020-12-31 |
| NCT02628379 |
Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary |
https://ClinicalTrials.gov/show/NCT02628379 |
Completed |
Foundation Medicine |
2017-03-31 |
| NCT03148665 |
Saliva-based Detection of CD44 |
https://ClinicalTrials.gov/show/NCT03148665 |
Active, not recruiting |
University of California, San Diego |
2019-04-10 |
| NCT02379039 |
Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer |
https://ClinicalTrials.gov/show/NCT02379039 |
Recruiting |
Umeå University |
2021-05-31 |
| NCT02549638 |
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02549638 |
Recruiting |
Mayo Clinic |
2020-08-31 |
| NCT02543476 |
SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) |
https://ClinicalTrials.gov/show/NCT02543476 |
Completed |
AstraZeneca |
2016-11-14 |
| NCT02279459 |
Dual-Energy CT in Patients With Head and Neck Squamous Cell Carcinomas |
https://ClinicalTrials.gov/show/NCT02279459 |
Completed |
Ottawa Hospital Research Institute |
2018-10-01 |
| NCT02245100 |
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02245100 |
Recruiting |
Thomas Jefferson University |
2020-07-31 |
| NCT02242916 |
State of the Art Photon Therapy Versus Particle Therapy for Recurrent Head & Neck Tumors; a Planning Study |
https://ClinicalTrials.gov/show/NCT02242916 |
Completed |
Maastricht Radiation Oncology |
2015-10-31 |
| NCT02147418 |
Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02147418 |
Recruiting |
New Mexico Cancer Care Alliance |
2021-01-31 |
| NCT02149602 |
A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck |
https://ClinicalTrials.gov/show/NCT02149602 |
Completed |
Royal Marsden NHS Foundation Trust |
2011-11-30 |
| NCT02145416 |
ART: Anal Squamous Cell Carcinoma: Investigation of Functional Imaging During chemoRadioTherapy |
https://ClinicalTrials.gov/show/NCT02145416 |
Completed |
University of Oxford |
2017-12-08 |
| NCT02139020 |
Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients |
https://ClinicalTrials.gov/show/NCT02139020 |
Recruiting |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2023-01-31 |
| NCT02095912 |
Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients |
https://ClinicalTrials.gov/show/NCT02095912 |
Completed |
University of Zurich |
2015-11-30 |
| NCT02003482 |
Prospective Trial of Serial CT Imaging for Evaluation of Dosimetric/Volumetric Changes During IMRT for Head/Neck Cancer |
https://ClinicalTrials.gov/show/NCT02003482 |
Completed |
University of Miami |
2018-03-26 |
| NCT01976468 |
Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The “SCOPE-ITSCC Metastases Study” |
https://ClinicalTrials.gov/show/NCT01976468 |
Active, not recruiting |
University of Zurich |
2023-01-31 |
| NCT01827956 |
Role of FCγRIIIA and FCγRIIA Receptor Polymorphisms |
https://ClinicalTrials.gov/show/NCT01827956 |
Completed |
Institut Bergonié |
2011-06-30 |
| NCT01783158 |
Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal Carcinoma |
https://ClinicalTrials.gov/show/NCT01783158 |
Completed |
University Hospital Ostrava |
2012-11-30 |
| NCT01540695 |
Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology |
https://ClinicalTrials.gov/show/NCT01540695 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2013-01-31 |
| NCT01500954 |
Microarray Analysis of microRNA Expression Profiles in Cutaneous Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01500954 |
Completed |
Ruhr University of Bochum |
2011-12-31 |
| NCT01472419 |
Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01472419 |
Completed |
Samsung Medical Center |
2012-12-31 |
| NCT01358097 |
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy |
https://ClinicalTrials.gov/show/NCT01358097 |
Completed |
Icahn School of Medicine at Mount Sinai |
2013-09-30 |
| NCT01321892 |
Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium |
https://ClinicalTrials.gov/show/NCT01321892 |
Completed |
Icahn School of Medicine at Mount Sinai |
2012-05-31 |
| NCT04260074 |
Epigenetic Changes in Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT04260074 |
Recruiting |
Aalborg University Hospital |
2020-07-31 |
| NCT04224389 |
IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas |
https://ClinicalTrials.gov/show/NCT04224389 |
Recruiting |
Gustave Roussy, Cancer Campus, Grand Paris |
2023-06-30 |
| NCT04224896 |
Narrow-Band Imaging (NBI) Versus Lugol Chromoendoscopy in the Detection of Oesophagus Squamous Cell Carcinoma in High Risk Population |
https://ClinicalTrials.gov/show/NCT04224896 |
Completed |
Hôpital Edouard Herriot |
2011-03-01 |
| NCT04218136 |
Cetuximab Therapeutic Drug Monitoring in Squamous Cell Carcinoma Head and Neck Cancer Patients: Determination of the Predictive Value Exposure Levels Through a Single Arm Multicentric Study |
https://ClinicalTrials.gov/show/NCT04218136 |
Recruiting |
Assistance Publique Hopitaux De Marseille |
2022-04-28 |
| NCT04201002 |
Surgery Plus Intraoperative Radiotherapy as Treatment for Squamous Cell Carcinoma Over Pilonidal Disease. |
https://ClinicalTrials.gov/show/NCT04201002 |
Completed |
Hospital Provincial de Castellon |
2019-10-11 |
| NCT04199832 |
To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer Patients Undergoing Chemoradiotherapy |
https://ClinicalTrials.gov/show/NCT04199832 |
Recruiting |
Tianjin Medical University Cancer Institute and Hospital |
2020-12-31 |
| NCT04183218 |
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes in Non-metastatic, Non-recurrent Lung and Esophageal Cancer Patients |
https://ClinicalTrials.gov/show/NCT04183218 |
Recruiting |
Mayo Clinic |
2021-09-23 |
| NCT04151134 |
Evaluation of Tongue Base MucOsectomy & Step sErial Sectioning |
https://ClinicalTrials.gov/show/NCT04151134 |
Recruiting |
Royal Marsden NHS Foundation Trust |
2020-11-01 |
| NCT04099290 |
Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT04099290 |
Recruiting |
UNC Lineberger Comprehensive Cancer Center |
2020-09-30 |
| NCT04086849 |
Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers |
https://ClinicalTrials.gov/show/NCT04086849 |
Recruiting |
Sunnybrook Health Sciences Centre |
2024-12-30 |
| NCT04050761 |
A Study of Nivolumab in Patients With Head and Neck Cancer. |
https://ClinicalTrials.gov/show/NCT04050761 |
Recruiting |
Bristol-Myers Squibb |
2024-06-26 |
| NCT04003025 |
Body Composition and Prognosis in Head and Neck Squamous Cell Carcinoma (HNSCC) |
https://ClinicalTrials.gov/show/NCT04003025 |
Recruiting |
Instituto do Cancer do Estado de São Paulo |
2020-07-31 |
| NCT03953443 |
Expression & Epigenetic Silencing of MicroRNA for Predicting Therapeutic Response and Prognosis of HPV-negative HNSCC |
https://ClinicalTrials.gov/show/NCT03953443 |
Enrolling by invitation |
New Mexico Cancer Care Alliance |
2025-12-31 |
| NCT03938012 |
Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03938012 |
Recruiting |
National University Hospital, Singapore |
2021-10-31 |
| NCT03877159 |
Analysis of the Variation in Caspase-8 Availability and Cleavage in Oral Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03877159 |
Recruiting |
Guy’s and St Thomas’ NHS Foundation Trust |
2020-01-30 |
| NCT03836105 |
CemiplimAb Survivorship Epidemiology |
https://ClinicalTrials.gov/show/NCT03836105 |
Recruiting |
Regeneron Pharmaceuticals |
2023-12-31 |
| NCT03759756 |
Artificial Intelligence for Early Diagnosis of Esophageal Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03759756 |
Completed |
Shandong University |
2020-03-01 |
| NCT03727594 |
Radioguided Selective Neck Dissection for Staging and Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03727594 |
Recruiting |
University Hospital of Ferrara |
2020-01-31 |
| NCT03712566 |
Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy |
https://ClinicalTrials.gov/show/NCT03712566 |
Active, not recruiting |
University Health Network, Toronto |
2022-10-31 |
| NCT03554967 |
Toluidine Blue Versus Frozen Sections for Assessment of Tumor Margins in Oral Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03554967 |
Completed |
Cairo University |
2019-06-03 |
| NCT03529604 |
Salivary Ap4A, SCCA, TROP2 in Oral Cancer Patients |
https://ClinicalTrials.gov/show/NCT03529604 |
Active, not recruiting |
University of Zagreb |
2020-04-01 |
| NCT03467529 |
Evaluation of Full-field Coherence Tomography for ex Vivo Staging and Assessment of Superficial Esophageal Squamous Carcinoma: a Pilot Study |
https://ClinicalTrials.gov/show/NCT03467529 |
Recruiting |
Nantes University Hospital |
2021-04-30 |
| NCT01179360 |
Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) |
https://ClinicalTrials.gov/show/NCT01179360 |
Completed |
University Hospital, Antwerp |
2015-12-31 |
| NCT01104714 |
Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers |
https://ClinicalTrials.gov/show/NCT01104714 |
Completed |
Centre Hospitalier Universitaire de NÄ«mes |
2014-07-31 |
| NCT01080066 |
A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN) |
https://ClinicalTrials.gov/show/NCT01080066 |
Completed |
Merck KGaA, Darmstadt, Germany |
2013-12-31 |
| NCT01075828 |
Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea |
https://ClinicalTrials.gov/show/NCT01075828 |
Completed |
Merck KGaA, Darmstadt, Germany |
2014-07-31 |
| NCT01043328 |
Human Papillomavirus on Oral Tissue, Saliva and Serum |
https://ClinicalTrials.gov/show/NCT01043328 |
Completed |
UPECLIN HC FM Botucatu Unesp |
2010-01-31 |
| NCT01017224 |
DAHANCA 24: Prognostic Value of 18F-FAZA in Head and Neck Squamous Cell Carcinoma (HNSCC) |
https://ClinicalTrials.gov/show/NCT01017224 |
Completed |
University of Aarhus |
2012-05-31 |
| NCT00897442 |
Collecting Tumor Samples From Patients With Gynecological Tumors |
https://ClinicalTrials.gov/show/NCT00897442 |
Completed |
Gynecologic Oncology Group |
2016-01-31 |
| NCT00901173 |
A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western Kenya |
https://ClinicalTrials.gov/show/NCT00901173 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-04-20 |
| NCT00875381 |
Analysis of Melanocytes (Pigment Cells) in Sun-Exposed Skin |
https://ClinicalTrials.gov/show/NCT00875381 |
Completed |
Mayo Clinic |
2007-12-31 |
| NCT00868725 |
Detecting Lesions in the Oral Cavity With Thermal Imaging |
https://ClinicalTrials.gov/show/NCT00868725 |
Completed |
Sheba Medical Center |
2009-06-30 |
| NCT03759730 |
Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03759730 |
Completed |
University Health Network, Toronto |
2018-11-28 |
| NCT03652142 |
Predictive Biomarkers for Response to Nivolumab in Head and Neck Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03652142 |
Recruiting |
Attikon Hospital |
2020-05-01 |
| NCT00793169 |
Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery |
https://ClinicalTrials.gov/show/NCT00793169 |
Completed |
Northwestern University |
2008-07-31 |
| NCT00662662 |
Sexual Behavior in Head and Neck Cancer Patients |
https://ClinicalTrials.gov/show/NCT00662662 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2022-05-31 |
| NCT00620139 |
Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00620139 |
Completed |
Memorial Sloan Kettering Cancer Center |
2013-10-31 |
| NCT00592371 |
Head and Neck Cancer Screening and Serum Repository |
https://ClinicalTrials.gov/show/NCT00592371 |
Completed |
University of Arkansas |
2012-09-30 |
| NCT00530283 |
PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy |
https://ClinicalTrials.gov/show/NCT00530283 |
Completed |
AHS Cancer Control Alberta |
2010-07-31 |
| NCT00195299 |
Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck |
https://ClinicalTrials.gov/show/NCT00195299 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00124488 |
Comparison of Tomotherapy Versus Intensity-modulated Step-and-shoot and Conventional Radiation Treatment Plans for Patients With Locally-advanced Squamous Cell Carcinoma of the Cervix |
https://ClinicalTrials.gov/show/NCT00124488 |
Completed |
AHS Cancer Control Alberta |
NA |
| NCT00011492 |
Patient Evaluation for Head and Neck Surgery Branch Studies |
https://ClinicalTrials.gov/show/NCT00011492 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00836342 |
Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer |
https://ClinicalTrials.gov/show/NCT00836342 |
Completed |
Massachusetts General Hospital |
2012-01-31 |
| NCT00001603 |
The Effects of Upper Airway and Digestive Tract Tumors on the Immune System |
https://ClinicalTrials.gov/show/NCT00001603 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |